Is Angiotensin-Converting Enzyme Inhibitor a Contraindication for Contrast-Induced Nephropathy Prophylaxis? A Review About its Paradox
Cardiovascular Therapeutics, 04/26/2012Li X et al.
Authors review the medical literatures and discuss the pathogenesis, the role of renin–angiotensin–aldosterone system on the development of contrast–induced nephropathy (CIN) and angiotensin–converting enzyme (ACE) inhibitors' effect on CIN.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.